Your browser doesn't support javascript.
COVID-19: therapeutic approaches description and discussion.
Trindade, Guilherme G; Caxito, Samyra M C; Xavier, Alessandra Rejane E O; Xavier, Mauro A S; BrandÃo, Fabiana.
  • Trindade GG; University of Brasília, Laboratory of Clinical Microbiology and Immunology, Campus Darcy Ribeiro, Asa Norte, 70910-900 Brasília, DF, Brazil.
  • Caxito SMC; AMIL/United Health Group (UHG), 6580, SMAS Trecho 1, Guará, 70211-970 Brasília, DF, Brazil.
  • Xavier AREO; Institute of Management and Health of the Federal District (IGES-DF), Department of Nursing, Quadra 400-600, s/n, Área Especial, Recanto das Emas, 72630-250 Brasília, DF, Brazil.
  • Xavier MAS; State University of Montes Claros, Center of Biological and Health Sciences, Microbiology Laboratory, Av. Prof. Rui Braga, 39401-089 Montes Claros, MG, Brazil.
  • BrandÃo F; State University of Montes Claros, Center of Biological and Health Sciences, Microbiology Laboratory, Av. Prof. Rui Braga, 39401-089 Montes Claros, MG, Brazil.
An Acad Bras Cienc ; 92(2): e20200466, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-608501
ABSTRACT
COVID-19 emerged in December 2019 in China, and since then, has disrupted global public health and changed economic paradigms. In dealing with the new Coronavirus, SARS-CoV-2, the world has not faced such extreme global fragility since the "Spanish flu" pandemic in 1918. Researchers globally are dedicating efforts to the search for an effective treatment for COVID-19. Drugs already used in a clinical setting for other pathologies have been tested as a new therapeutic approach against SARS-CoV-2, setting off a frenzy over the preliminary data of different studies. This work aims to compile and discuss the data published thus far. Despite the potential effects of some antivirals and antiparasitic against COVID-19, clinical studies must confirm real effectiveness. However, non-pharmacological approaches have proven to be the most efficient strategy to date.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Inhibidores de Serina Proteinasa / Infecciones por Coronavirus / Macrólidos / Betacoronavirus / Antibacterianos / Antiparasitarios Tipo de estudio: Estudio pronóstico Límite: Humanos Idioma: Inglés Revista: An Acad Bras Cienc Año: 2020 Tipo del documento: Artículo País de afiliación: 0001-3765202020200466

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Inhibidores de Serina Proteinasa / Infecciones por Coronavirus / Macrólidos / Betacoronavirus / Antibacterianos / Antiparasitarios Tipo de estudio: Estudio pronóstico Límite: Humanos Idioma: Inglés Revista: An Acad Bras Cienc Año: 2020 Tipo del documento: Artículo País de afiliación: 0001-3765202020200466